EGF and chronic obstructive pulmonary disease: In conclusion, we describe that EGFR inhibition promotes the ST muscle phenotype, a mechanism that appears conserved across species and scenarios of both myogenesis and fiber maintenance, and that increased EGF signaling is associated with a loss of the ST phenotype in COPD patients as well as being negatively associated with the ST muscle phenotype in mice.